Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erland Axelsson

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
BMJ Open|August 31, 2025
Equivalence and non-inferiority trials in the evaluation of non-pharmacological interventions: rationale, challenges and recommendationsErland Axelsson
Journal of Psychosomatic Research|January 9, 2023
Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter?Erland Axelsson, Erik Hedman-Lagerlöf
Psychology and Psychotherapy|March 27, 2025
Associations between treatment credibility, patient expectancies, working alliance and symptom trajectory in cognitive behaviour therapy for pathological health anxietyErland Axelsson, Erik Hedman-Lagerlöf
Expert Review of Pharmacoeconomics & Outcomes Research|August 24, 2023
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trialsErland Axelsson, Erik Hedman-Lagerlöf
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2019
Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomesErland Axelsson, Erik Hedman-Lagerlöf
BMC Psychiatry|September 6, 2023
Joint factor analysis and approximate equipercentile linking of common trait health anxiety measures: a cross-sectional study of the 14-, 18- and 64-item health anxiety inventory, the illness attitude scale, and the 14-item Whiteley IndexErland Axelsson, Susanna Österman, Erik Hedman-Lagerlöf
Behavioural and Cognitive Psychotherapy|November 21, 2023
Brief scales for the measurement of target variables and processes of change in cognitive behaviour therapy for major depression, panic disorder and social anxiety disorderErland Axelsson, Fredrik Santoft, Josefin Särnholm, et al.
Behavioural and Cognitive Psychotherapy|December 5, 2024
Development and psychometric properties of the Health Anxiety Behavior Inventory (HABI)Erik Hedman-Lagerlöf, Daniel Björkander, Erik Andersson, et al.
Behaviour Research and Therapy|June 25, 2018
Cost-effectiveness and long-term follow-up of three forms of minimal-contact cognitive behaviour therapy for severe health anxiety: Results from a randomised controlled trialErland Axelsson, Erik Andersson, Brjánn Ljótsson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 6, 2016
Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trialErik Hedman, Erland Axelsson, Erik Andersson, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
BMJ Open|August 31, 2025
Equivalence and non-inferiority trials in the evaluation of non-pharmacological interventions: rationale, challenges and recommendationsErland Axelsson
Journal of Psychosomatic Research|January 9, 2023
Validity and clinical utility of distinguishing between DSM-5 somatic symptom disorder and illness anxiety disorder in pathological health anxiety: Should we close the chapter?Erland Axelsson, Erik Hedman-Lagerlöf
Psychology and Psychotherapy|March 27, 2025
Associations between treatment credibility, patient expectancies, working alliance and symptom trajectory in cognitive behaviour therapy for pathological health anxietyErland Axelsson, Erik Hedman-Lagerlöf
Expert Review of Pharmacoeconomics & Outcomes Research|August 24, 2023
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trialsErland Axelsson, Erik Hedman-Lagerlöf
Expert Review of Pharmacoeconomics & Outcomes Research|December 21, 2019
Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomesErland Axelsson, Erik Hedman-Lagerlöf
BMC Psychiatry|September 6, 2023
Joint factor analysis and approximate equipercentile linking of common trait health anxiety measures: a cross-sectional study of the 14-, 18- and 64-item health anxiety inventory, the illness attitude scale, and the 14-item Whiteley IndexErland Axelsson, Susanna Österman, Erik Hedman-Lagerlöf
Behavioural and Cognitive Psychotherapy|November 21, 2023
Brief scales for the measurement of target variables and processes of change in cognitive behaviour therapy for major depression, panic disorder and social anxiety disorderErland Axelsson, Fredrik Santoft, Josefin Särnholm, et al.
Behavioural and Cognitive Psychotherapy|December 5, 2024
Development and psychometric properties of the Health Anxiety Behavior Inventory (HABI)Erik Hedman-Lagerlöf, Daniel Björkander, Erik Andersson, et al.
Behaviour Research and Therapy|June 25, 2018
Cost-effectiveness and long-term follow-up of three forms of minimal-contact cognitive behaviour therapy for severe health anxiety: Results from a randomised controlled trialErland Axelsson, Erik Andersson, Brjánn Ljótsson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 6, 2016
Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trialErik Hedman, Erland Axelsson, Erik Andersson, et al.
Pageof 6